For a limited time, new participants can receive a special bonus

Who may participate

icon of 3 people with blue and teal outlineClinical trials are key to developing potential life-changing treatments for people across the globe. But they can't happen without participants.

This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied. In addition to the criteria listed, participants must meet the following requirements:

  • Willing to take a study drug
  • Able to meet all study visit requirements
  • Willing and able to travel to our facility in New Haven, CT for screening and participation

There are other requirements for participation in this study. The study staff will explain these to you during the screening process.


Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.

The disease, disorder, syndrome, illness, or injury that is being studied. On, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

18-60 years

The age a person must be to participate in a clinical trial.

All sexes

The sex of people who may participate in a clinical trial. Sex is a person’s classification based on assignment at birth. Eligibility based on sex is distinct from eligibility based on gender.

Referral Bonus
Up to $250

Click “Get Started” for program details. Compensation may be provided on a loadable debit card or by paper check in US dollars. The New Haven PCRU reserves the right to determine method of payment, determine eligibility, or change or terminate this program at any time.

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

icon of a blue and teal clipboardIf this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT.

If you participate, you will stay at our facility for 18 nights during one stay. During your stay, you will receive the drug under study, a drug used to boost the amount of the study drug in your blood, and an additional medication to see if and how they interact. All doses will be given orally in line with the following schedule:

Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood. All of the study procedures will be clearly explained to you during screening and can be viewed in the consent form below.

Required overnight stays
18 consecutive overnights

A participant may be required to stay overnight at the PCRU for observation and study procedures. The number and length of overnight stays is determined by the design of the study.

Long-term follow up
1 phone-call

Some studies require the study team to stay in contact with the participant for a period of time after the participant completes the main part of the study. This long-term follow up is to collect additional information on the study drug over time.

How long is this study?
Up to 54 days

This does not include the time between screening and dosing, which can be up to 28 days. Participants will be in this study for about 54 days between the first admission and final follow-up call.

Up to $5,800 upon completion of the study

Participants in clinical trials at the PCRU receive financial compensation for their participation. The amount depends on factors like length of the stay, total number of study visits, and the nature of the study procedures.

Interested in participating?

Complete and submit this form, and a Pfizer Clinical Research Unit (PCRU) representative will contact you.

You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.

The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research units database. We may use this information to invite you to participate in this clinical study, as well as other current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.